Literature DB >> 15802644

Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease.

Olga V Bocharova1, Leonid Breydo, Vadim V Salnikov, Andrew C Gill, Ilia V Baskakov.   

Abstract

In recent studies, the amyloid form of recombinant prion protein (PrP) encompassing residues 89-230 (rPrP 89-230) produced in vitro induced transmissible prion disease in mice. These studies showed that unlike "classical" PrP(Sc) produced in vivo, the amyloid fibrils generated in vitro were more proteinase-K sensitive. Here we demonstrate that the amyloid form contains a proteinase K-resistant core composed only of residues 152/153-230 and 162-230. The PK-resistant fragments of the amyloid form are similar to those observed upon PK digestion of a minor subpopulation of PrP(Sc) recently identified in patients with sporadic Creutzfeldt-Jakob disease (CJD). Remarkably, this core is sufficient for self-propagating activity in vitro and preserves a beta-sheet-rich fibrillar structure. Full-length recombinant PrP 23-230, however, generates two subpopulations of amyloid in vitro: One is similar to the minor subpopulation of PrP(Sc), and the other to classical PrP(Sc). Since no cellular factors or templates were used for generation of the amyloid fibrils in vitro, we speculate that formation of the subpopulation of PrP(Sc) with a short PK-resistant C-terminal region reflects an intrinsic property of PrP rather than the influence of cellular environments and/or cofactors. Our work significantly increases our understanding of the biochemical nature of prion infectious agents and provides a fundamental insight into the mechanisms of prions biogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802644      PMCID: PMC2253268          DOI: 10.1110/ps.041186605

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  62 in total

1.  Pathway complexity of prion protein assembly into amyloid.

Authors:  Ilia V Baskakov; Giuseppe Legname; Michael A Baldwin; Stanley B Prusiner; Fred E Cohen
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

2.  Structural studies of the scrapie prion protein by electron crystallography.

Authors:  Holger Wille; Melissa D Michelitsch; Vincent Guenebaut; Surachai Supattapone; Ana Serban; Fred E Cohen; David A Agard; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

3.  A prion protein epitope selective for the pathologically misfolded conformation.

Authors:  Eustache Paramithiotis; Marc Pinard; Trebor Lawton; Sylvie LaBoissiere; Valerie L Leathers; Wen-Quan Zou; Lisa A Estey; Julie Lamontagne; Marty T Lehto; Leslie H Kondejewski; Gregory P Francoeur; Maria Papadopoulos; Ashkan Haghighat; Stephen J Spatz; Mark Head; Robert Will; James Ironside; Katherine O'Rourke; Quentin Tonelli; Harry C Ledebur; Avi Chakrabartty; Neil R Cashman
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

4.  Evolution of a strain of CJD that induces BSE-like plaques.

Authors:  L Manuelidis; W Fritch; Y G Xi
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

5.  Identification of the heparan sulfate binding sites in the cellular prion protein.

Authors:  Richard G Warner; Christoph Hundt; Stefan Weiss; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2002-03-06       Impact factor: 5.157

6.  Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain.

Authors:  D A Kocisko; P T Lansbury; B Caughey
Journal:  Biochemistry       Date:  1996-10-15       Impact factor: 3.162

7.  Strain-specified characteristics of mouse synthetic prions.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; Ilia V Baskakov; Fred E Cohen; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

8.  Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein.

Authors:  C I Lasmézas; J P Deslys; O Robain; A Jaegly; V Beringue; J M Peyrin; J G Fournier; J J Hauw; J Rossier; D Dormont
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

9.  Molecular classification of sporadic Creutzfeldt-Jakob disease.

Authors:  Andrew F Hill; Susan Joiner; Jonathan D F Wadsworth; Katie C L Sidle; Jeanne E Bell; Herbert Budka; James W Ironside; John Collinge
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

10.  Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges.

Authors:  Reinerio González-Iglesias; María A Pajares; Carmen Ocal; Juan Carlos Espinosa; Bruno Oesch; María Gasset
Journal:  J Mol Biol       Date:  2002-05-31       Impact factor: 5.469

View more
  44 in total

1.  The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance.

Authors:  Robert Tycko; Regina Savtchenko; Valeriy G Ostapchenko; Natallia Makarava; Ilia V Baskakov
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  High pressure, a tool to switch between soluble and fibrillar prion protein structures.

Authors:  Joan Torrent; Reinhard Lange
Journal:  Commun Integr Biol       Date:  2012-01-01

3.  Probing the conformation of a prion protein fibril with hydrogen exchange.

Authors:  Steven M Damo; Aaron H Phillips; Anisa L Young; Sheng Li; Virgil L Woods; David E Wemmer
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

Review 4.  Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C).

Authors:  Andrew C Gill; Sonya Agarwal; Teresa J T Pinheiro; James F Graham
Journal:  Prion       Date:  2010-10-20       Impact factor: 3.931

5.  Nonpolar substitution at the C-terminus of the prion protein, a mimic of the glycosylphosphatidylinositol anchor, partially impairs amyloid fibril formation.

Authors:  Leonid Breydo; Ying Sun; Natallia Makarava; Cheng-I Lee; Vera Novitskaia; Olga Bocharova; Joseph P Y Kao; Ilia V Baskakov
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

6.  Mechanisms of prion protein assembly into amyloid.

Authors:  Jan Stöhr; Nicole Weinmann; Holger Wille; Tina Kaimann; Luitgard Nagel-Steger; Eva Birkmann; Giannantonio Panza; Stanley B Prusiner; Manfred Eigen; Detlev Riesner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

7.  The dominant-negative effect of the Q218K variant of the prion protein does not require protein X.

Authors:  Cheng I Lee; Qingyuan Yang; Veronique Perrier; Ilia V Baskakov
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

8.  Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size.

Authors:  Ying Sun; Natallia Makarava; Cheng-I Lee; Pongpan Laksanalamai; Frank T Robb; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2008-01-03       Impact factor: 5.469

9.  Purification and Fibrillation of Full-Length Recombinant PrP.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  Methods Mol Biol       Date:  2017

Review 10.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.